Showing results (631-640 of 670) with videos related to
Sort By:
Pageof 67
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 5, 2026
Evidence-based guidelines for the use of extracorporeal membrane oxygenation in Australia and New Zealand using GRADE methodology series part 1: Venovenous extracorporeal membrane oxygenation (VV ECMO) indications and managementSally F Newman, Aidan Burrell, Hergen Buscher, et al.Bioinformatics Advances|April 27, 2026
Leveraging training expertise to build capacity in computational personalised medicineMarta Lloret-Llinares, Daniel Thomas-Lopez, José Carbonell-Caballero, et al.Oncotarget|June 23, 2016
Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitorsAmanda M Smith, Matthew D Dun, Erwin M Lee, et al.Plos Pathogens|November 16, 2022
Cryo-EM reveals the conformational epitope of human monoclonal antibody PAM1.4 broadly reacting with polymorphic malarial protein VAR2CSASai Sundar Rajan Raghavan, Robert Dagil, Mary Lopez-Perez, et al.Blood|October 7, 2009
Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AMLJason A Powell, Daniel Thomas, Emma F Barry, et al.Proceedings of the National Academy of Sciences of the United States of America|January 3, 2006
Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigenNatalia A Ponomarenko, Oxana M Durova, Ivan I Vorobiev, et al.Intensive Care Medicine|August 26, 2024
Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patientsNiklas Bruse, Anna Motos, Rombout van Amstel, et al.Proceedings of the National Academy of Sciences of the United States of America|March 23, 2026
CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitinationRuhi Polara, Briony L Gliddon, Raja Ganesan, et al.Science Translational Medicine|March 4, 2016
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in gliomaCarl Koschmann, Anda-Alexandra Calinescu, Felipe J Nunez, et al.Blood|January 2, 2026
Ultraprecision Therapy for Type 1 vs Type 2 CALR+ MPN by Dual Epitope Targeting that Restores Ruxolitinib SensitivityChloe Al Thompson-Peach, Daniel Thomas, Mara Dottore, et al.Pageof 67